Exact Mass: 465.1835

Exact Mass Matches: 465.1835

Found 29 metabolites which its exact mass value is equals to given mass value 465.1835, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Cisapride

4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide

C23H29ClFN3O4 (465.1831)


In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].

   

cisapride

4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide

C23H29ClFN3O4 (465.1831)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].

   

Cys Gly Met Arg

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Cys Gly Arg Met

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Cys Met Gly Arg

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Cys Met Arg Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Cys Arg Gly Met

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Cys Arg Met Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Gly Cys Met Arg

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Gly Cys Arg Met

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Gly Met Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Gly Met Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

Gly Arg Cys Met

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Gly Arg Met Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

Met Cys Gly Arg

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Met Cys Arg Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Met Gly Cys Arg

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5S2 (465.1828)


   

Met Gly Arg Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

Met Arg Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Met Arg Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

Arg Cys Gly Met

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Arg Cys Met Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Arg Gly Cys Met

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H31N7O5S2 (465.1828)


   

Arg Gly Met Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

Arg Met Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetic acid

C16H31N7O5S2 (465.1828)


   

Arg Met Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanoic acid

C16H31N7O5S2 (465.1828)


   

N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE

N-(3,5-DICHLORO-2-HYDROXY-4-METHYLPHENYL)-2-(2,4-DI-TERT-PENTYLPHENOXY)-ACETAMIDE

C25H33Cl2NO3 (465.1837)


   

2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide

2-[[2-(1-benzotriazolyl)-1-oxoethyl]-(thiophen-2-ylmethyl)amino]-2-(2-furanyl)-N-(3-methylbutyl)acetamide

C24H27N5O3S (465.1835)


   

Propulsid

Propulsid

C23H29ClFN3O4 (465.1831)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].